These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29265939)

  • 1. One-Year Outcome of Conbercept Therapy for Diabetic Macular Edema.
    Li F; Zhang L; Wang Y; Xu W; Jiao W; Ma A; Zhao B
    Curr Eye Res; 2018 Feb; 43(2):218-223. PubMed ID: 29265939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperreflective foci in OCT image as a biomarker of poor prognosis in diabetic macular edema patients treating with Conbercept in China.
    Liu S; Wang D; Chen F; Zhang X
    BMC Ophthalmol; 2019 Jul; 19(1):157. PubMed ID: 31337360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 12-month therapeutic effect of conbercept and ranibizumab for diabetic macular edema: a real-life clinical practice study.
    Xu Y; Rong A; Xu W; Niu Y; Wang Z
    BMC Ophthalmol; 2017 Aug; 17(1):158. PubMed ID: 28841827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year outcomes of novel VEGF decoy receptor therapy with intravitreal conbercept in diabetic retinopathy-induced macular edema.
    Zhou Q; Guo C; You A; Wang D; Wang W; Zhang X
    Mol Vis; 2019; 25():636-644. PubMed ID: 31700228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment response to Conbercept of different types of diabetic macular edema classified based on optical coherence tomography].
    Zhang Y; Yao J; Quan Y; Wang J; Xing Y; Zhou A
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1501-1508. PubMed ID: 34755665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: A Secondary Analysis of a Randomized Clinical Trial.
    Glassman AR; Baker CW; Beaulieu WT; Bressler NM; Punjabi OS; Stockdale CR; Wykoff CC; Jampol LM; Sun JK;
    JAMA Ophthalmol; 2020 Apr; 138(4):341-349. PubMed ID: 32077907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Conbercept with Ranibizumab for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Li F; Sun M; Guo J; Ma A; Zhao B
    Curr Eye Res; 2017 Aug; 42(8):1174-1178. PubMed ID: 28441077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fellow eye effect of unilateral intravitreal conbercept injections in eyes with diabetic macular edema.
    Di Y; Li Z; Ye J; Li L; Li B; Yu R
    Acta Diabetol; 2020 Aug; 57(8):1001-1007. PubMed ID: 32215730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
    Solaiman KA; Diab MM; Abo-Elenin M
    Retina; 2010; 30(10):1638-45. PubMed ID: 20838357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study.
    Busch C; Fraser-Bell S; Zur D; Rodríguez-Valdés PJ; Cebeci Z; Lupidi M; Fung AT; Gabrielle PH; Giancipoli E; Chaikitmongkol V; Okada M; Laíns I; Santos AR; Kunavisarut P; Sala-Puigdollers A; Chhablani J; Ozimek M; Hilely A; Unterlauft JD; Loewenstein A; Iglicki M; Rehak M;
    Acta Diabetol; 2019 Jul; 56(7):777-784. PubMed ID: 30903434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Efficacy of Intravitreal Conbercept Injections with or without Focal Macular Photocoagulation for Diabetic Macular Edema.
    Mao Y; Wang S; Ji X; Cao K; Hou S; Xiao Y
    Altern Ther Health Med; 2023 Jul; 29(5):308-313. PubMed ID: 37171942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study.
    Pearce I; Banerjee S; Burton BJ; Chakravarthy U; Downey L; Gale RP; Gibson J; Pagliarini S; Patel J; Sivaprasad S; Andrews C; Brittain C; Warburton J;
    Ophthalmology; 2015 Sep; 122(9):1811-9. PubMed ID: 26150052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of early dexamethasone retreatment versus standard dexamethasone regimen combined with PRN ranibizumab in diabetic macular edema.
    Arıkan Yorgun M; Toklu Y; Mutlu M
    Int Ophthalmol; 2017 Feb; 37(1):185-196. PubMed ID: 27173834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.
    Augustin AJ; Kuppermann BD; Lanzetta P; Loewenstein A; Li XY; Cui H; Hashad Y; Whitcup SM;
    BMC Ophthalmol; 2015 Oct; 15():150. PubMed ID: 26519345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of retinal layer changes with vision gain in diabetic macular edema during conbercept treatment.
    Xu Y; Qu Y; Suo Y; Gao J; Chen X; Liu K; Xu X
    BMC Ophthalmol; 2019 May; 19(1):123. PubMed ID: 31151389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema.
    Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J
    BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHANGES IN CENTRAL CHOROIDAL THICKNESS AFTER TREATMENT OF DIABETIC MACULAR EDEMA WITH INTRAVITREAL BEVACIZUMAB CORRELATION WITH CENTRAL MACULAR THICKNESS AND BEST-CORRECTED VISUAL ACUITY.
    Nourinia R; Ahmadieh H; Nekoei E; Malekifar P; Tofighi Z
    Retina; 2018 May; 38(5):970-975. PubMed ID: 28426622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study.
    Liu K; Wang H; He W; Ye J; Song Y; Wang Y; Liu X; Wu Z; Chen S; Fan K; Liu Y; Zhang F; Li Z; Liu L; Zhang J; Zhang X; Ye J; Liang X; Li X; Ke X; Wu Q; Li J; Tao S; Wang X; Rosenfeld P; Heier JS; Kaiser P; Xu X
    Br J Ophthalmol; 2022 Oct; 106(10):1436-1443. PubMed ID: 34001667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
    Soheilian M; Ramezani A; Obudi A; Bijanzadeh B; Salehipour M; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Peyman GA
    Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Factors for Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Dexamethasone Implant.
    Lee H; Kang KE; Chung H; Kim HC
    Korean J Ophthalmol; 2018 Apr; 32(2):116-125. PubMed ID: 29560616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.